相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hepatitis D: not a rare disease anymore: global update for 2017-2018
Dan-Ting Shen et al.
GUT (2020)
Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta-analysis
Hai-Yan Chen et al.
GUT (2019)
Recombinant identification, molecular classification and proposed reference genomes for hepatitis delta virus
Zhijiang Miao et al.
JOURNAL OF VIRAL HEPATITIS (2019)
Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial
Heiner Wedemeyer et al.
LANCET INFECTIOUS DISEASES (2019)
Enveloped viruses distinct from HBV induce dissemination of hepatitis D virus in vivo
Jimena Perez-Vargas et al.
NATURE COMMUNICATIONS (2019)
Devil hepatitis D: an orphan disease or largely underdiagnosed?
Heiner Wedemeyer et al.
GUT (2019)
Treating chronic hepatitis delta: The need for surrogate markers of treatment efficacy
Cihan Yurdaydin et al.
JOURNAL OF HEPATOLOGY (2019)
New insights into HDV-induced innate immunity: MDA5 senses HDV replication
Aleksei Suslov et al.
JOURNAL OF HEPATOLOGY (2018)
Report from the International Conference on Viral Hepatitis-2017
Vicente Soriano et al.
AIDS REVIEWS (2018)
Hepatitis D virus replication is sensed by MDA5 and induces IFN-beta/lambda responses in hepatocytes
Zhenfeng Zhang et al.
JOURNAL OF HEPATOLOGY (2018)
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Spencer L. G. James et al.
LANCET (2018)
Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study
Devin Razavi-Shearer et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2018)
Antiviral Treatment and Liver- Related Complications in Hepatitis Delta
Anika Wranke et al.
HEPATOLOGY (2017)
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Theo Vos et al.
LANCET (2017)
Prevalence of hepatitis D virus infection in sub-Saharan Africa: a systematic review and meta-analysis
Alexander J. Stockdale et al.
LANCET GLOBAL HEALTH (2017)
Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review
Louisa Degenhardt et al.
LANCET GLOBAL HEALTH (2017)
The hepatitis delta virus: Replication and pathogenesis
Camille Sureau et al.
JOURNAL OF HEPATOLOGY (2016)
Wide variation in estimates of global prevalence and burden of chronic hepatitis B and C infection cited in published literature
S. K. Basnayake et al.
JOURNAL OF VIRAL HEPATITIS (2016)
Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement
Gretchen A. Stevens et al.
LANCET (2016)
Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis
Lucy Platt et al.
LANCET INFECTIOUS DISEASES (2016)
Hepatitis delta virus: insights into a peculiar pathogen and novel treatment options
Florian A. Lempp et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)
Hepatocarcinogenesis associated with hepatitis B, delta and C viruses
Elham Shirvani-Dastgerdi et al.
CURRENT OPINION IN VIROLOGY (2016)
Development and evaluation of a baseline-event-anticipation score for hepatitis delta
B. Calle Serrano et al.
JOURNAL OF VIRAL HEPATITIS (2014)
The Impact of Vaccination and Antiviral Therapy on Hepatitis B and Hepatitis D Epidemiology
Ashish Goyal et al.
PLOS ONE (2014)
Hepatitis D Virus Coinfection and Superinfection
Francesco Negro
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2014)
Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma
Alla Arzumanyan et al.
NATURE REVIEWS CANCER (2013)
Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews
Paul K. Nelson et al.
LANCET (2011)
A 28-Year Study of the Course of Hepatitis Δ Infection: A Risk Factor for Cirrhosis and Hepatocellular Carcinoma
Raffaella Romeo et al.
GASTROENTEROLOGY (2009)
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
David Moher et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Large hepatitis delta antigen modulates transforming growth factor-beta signaling cascades: Implication of hepatitis delta virus-induced liver fibrosis
Soo-Ho Choi et al.
GASTROENTEROLOGY (2007)
Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B
G Fattovich et al.
GUT (2000)
分享论文
